Today, On 17th October, The Supreme Court dismissed Roche’s appeal challenging the Delhi High Court’s refusal to restrain Natco Pharma from producing Risdiplam for Spinal Muscular Atrophy, observing it would not interfere since the High Court’s concurrent findings were interim in nature.
